Ask AI
Beyond A1C in T2D TM 1

CE / CME

Looking Beyond A1C in T2D Care: Cardiovascular and Kidney Risk Assessment

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

ABIM MOC: maximum of 0.50 Medical Knowledge MOC point

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Released: August 10, 2026

Expiration: August 09, 2027

Activity

Progress
1 2 3
Course Completed

References

  1. Centers for Disease Control and Prevention. A1C test for diabetes and prediabetes. cdc.gov/diabetes/diabetes-testing/prediabetes-a1c-test.html. Accessed July 30, 2026.
  2. American Diabetes Association Professional Practice Committee for Diabetes*. 6. Glycemic goals, hypoglycemia, and hyperglycemic crises: standards of care in diabetes-2026. Diabetes Care. 2026;49(Supplement_1):S132-S149.
  3. American Diabetes Association Professional Practice Committee for Diabetes*. 9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S183-S215.
  4. Writing Committee Members; Ndumele CE, Rodriguez F, Dixon DL, et al. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2026;154:e50-e158.
  5. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117-S314.
  6. American Diabetes Association Professional Practice Committee for Diabetes*. 8. Obesity and weight management for the prevention and treatment of diabetes: standards of care in diabetes-2026. Diabetes Care. 2026;49(Suppl 1):S166-S182.
  7. Marx N, Federici M, Schütt K, et al; ESC Scientific Document Group. 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. Eur Heart J. 2023;44:4043-4140.
  8. Semaglutide [prescribing information]. Plainsboro, NJ: Novo Nordisk Inc.; 2026.
  9. Hu Z, Tian D, Yang Z, et al. The mechanisms of GLP-1 receptor agonists in liver diseases: their multifaceted impact on immune response and metabolic regulation. Front Pharmacol. 2026;17:1754721.
  10. Checa-Ros A, Okojie OJ, Wassouf JG, et al. Glucagon-like peptide receptor agonists and kidney outcomes in the era of personalized medicine: focus on albuminuria. J Pers Med. 2026;16:97.